Sufia Husain

Dr. Sufia Husain

orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2016 in Saudi Medical Journal
Verified
Journal Article
Open access
PDF file
NANorah A. Alnegheimish
Norah A. Alnegheimish
RARazan A. Alshatwi
Razan A. Alshatwi
RAReem M. Alhefdhi
Reem M. Alhefdhi
MAMaha M. Arafah
Maha M. Arafah
AAAmmar C. AlRikabi
Ammar C. AlRikabi
SHSufia Husain
Sufia Husain
Molecular subtypes of breast carcinoma in Saudi Arabia. A retrospective study

11 July 2024 in Frontiers in Bioscience-Landmark
Verified
Journal Article
Open access
PDF file
SHSufia Husain
Sufia Husain
Podocytes are epithelial cells lining the outer surface of the renal glomerular capillaries and they play a pivotal role in maintaining the structural and functional integrity of the glomerular filtration barrier. Podocytes react to injury in various ways and any injury to these highly specialized cells can progress to podocyte dysfunction, resulting in a group of proteinuric renal diseases called podocytopathies. Podocytopathies include a wide spectrum of primary and secondary kidney diseases, including minimal change disease, diffuse mesangial sclerosis, focal segmental glomerulosclerosis, collapsing glomerulopathy, diabetic, membranous and lupus nephropathies. Etiologically, they can be idiopathic, genetic or secondary to infections and drugs, metabolic diseases, hemodynamic factors or associated with various immune and non-immune systemic diseases. This manuscript provides a basic understanding of podocyte structure, causes of podocyte injury, response to the injury and the subsequent progression to podocytopathies. The pathogenesis of these diseases is set around podocytes. The clinical and morphological manifestations, the commonality and heterogeneity of these podocytopathies are also discussed. As our knowledge of podocyte biology improves, so will our treatment avenues with a more podocyte-centric personalized approach.

1 April 2015 in Saudi Medical Journal
Verified
Journal Article
Open access
PDF file
MSMuslim M. Saadi
Muslim M. Saadi
DBDuna H. Barakeh
Duna H. Barakeh
SHSufia Husain
Sufia Husain
WHWaseem M. Hajjar
Waseem M. Hajjar
Large multicystic pulmonary chondroid hamartoma in a child presenting as pneumothorax

12 December 2018 in BMC Ophthalmology
Verified
Journal Article
Open access
PDF file
AAAnas Albarrak
Anas Albarrak
YMYousef Mohammad
Yousef Mohammad
SHSajjad Hussain
Sajjad Hussain
SHSufia Husain
Sufia Husain
TMTaim Abdullah Muayqil
Taim Abdullah Muayqil
This report highlights a rare case of simultaneous bilateral blindness due to posterior ischemic optic neuropathy. Typically, ophthalmic involvement in giant cell arteritis is monocular or sequential ischemia of the anterior portion of the optic nerve, and less frequently simultaneous. An 80-year-old Saudi male came with a history of simultaneous bilateral vision loss 5 days prior to presentation. The exam showed dilated non-reactive pupils, no light perception in both eyes, and normal fundus exam. C-reactive protein and erythrocyte sedimentation rate levels were high Magnetic resonance imaging and magnetic resonance angiography of the brain showed a right posterior optic nerve lesion and absence of flow in both ophthalmic arteries respectively. A left temporal artery biopsy confirmed giant cell arteritis. The presentation of GCA can be atypical and patients may present with simultaneous blindness. Bilateral simultaneous PION does not exclusively occur in a post surgical setting, emphasizing the importance of decreasing the threshold of suspicion of similar cases to avoid further neurological complications.

3 September 2018 in Ultrastructural Pathology
Verified
Journal Article
Closed access
SHSufia Husain
Sufia Husain
IGIbrahim Ginawi
Ibrahim Ginawi
ABAbdelhafiz Ibrahim Bashir
Abdelhafiz Ibrahim Bashir
HKHala Kfoury
Hala Kfoury
TJTariq Eid Al Johani
Tariq Eid Al Johani
AAAbdulkareem Alsuwaida
Abdulkareem Alsuwaida
Aim: Focal segmental glomerulosclerosis (FSGS) is a common progressive chronic renal disease. Podocyte injury and loss are the postulated pivotal events that trigger FSGS. In this study, the authors aim to examine the evolution of FSGS in murine models histologically, ultrastructurally and immunohistochemically with special emphasis on podocytes and parietal epithelial cells (PECs). Material and methods: FSGS resembling primary FSGS in humans was initiated in Wistar rats using intravenous Adriamycin injections. Blood and urine analysis were performed at 0, 8, and 12 weeks. Both the control kidneys and the test kidneys were harvested at 8 and 12 weeks, examined histologically and ultrastructurally and the findings correlated with the glomerular expression of immunostains specific for podocytes (WT-1) and for activated PECs (CD44). Results: FSGS developed in both 8 and 12 weeks test groups showing progressive proteinuria, podocytopathy and segmental glomerular scarring. There was a decrease in the glomerular expression of WT-1 with a concurrent increase in the glomerular expression of CD44, indicating podocyte loss with synchronous increase in activated PECs. The evolving FSGS correlated negatively with podocytes and positively with activated PECs. Conclusion: Our study shows that with podocyte injury there is podocyte effacement and loss, proteinuria, glomerular segmental adhesion and scarring, all culminating in FSGS. In addition, there is activation, hyperplasia and hypertrophy of PECs. This demonstrates that both podocyte loss and PEC activation promote FSGS. Our findings are consistent with recent investigations. More studies are required to further understand the role of these cells in the evolution of FSGS and subsequently introduce new targeted treatment modalities.

1 May 2017 in Saudi Medical Journal
Verified
Journal Article
Open access
SHSufia Husain
Sufia Husain
Collapsing glomerulopathy, the Saudi Arabian scenario. A study of 31 cases and a review of literature